Concord Wealth Partners’s NEVRO CORP. NVRO Stock Holding History

Concord Wealth Partners’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-13	Closed	-$2K	–	1071
2020 Q4	$2K	Buy	+13	New	+$2.1K	﹤0.01%	575

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Concord Wealth Partners's NVRO Position: Q1 2021 in Review

Concord Wealth Partners sold out of NEVRO CORP. (NVRO) in Q1 2021, closing a stake of 13 shares — an estimated $2K sold.

Concord Wealth Partners first reported a position in NVRO in Q4 2020 and held it in 1 quarter. The position peaked at $2K in Q4 2020. 204 funds tracked by Wall St. Rank hold NVRO as of Q1 2021.

Concord Wealth Partners reported no remaining NEVRO CORP. position as of Q1 2021 after selling out during the quarter.
Concord Wealth Partners sold 13 NEVRO CORP. shares in Q1 2021, an estimated $2K.
Concord Wealth Partners first reported a position in NEVRO CORP. in Q4 2020 and held it in 1 quarter.
Concord Wealth Partners's NEVRO CORP. position peaked at $2K in Q4 2020.
204 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2021.

Based on Concord Wealth Partners's 13F filing for Q1 2021, filed 13 May 2021.